Search
for
Sort by
Research 91–120 of 1000+
- STEROID HORMONES IN GERIATRICS
- Medicaid coverage of Janus kinase inhibitors for alopecia areata treatment
- Autoimmunity and homoeopathy: A narrative review of therapeutic perspectives, clinical evidence, and immunomodulatory insights
- Comorbidities in primary cicatricial alopecia: a systematic review and meta-analysis
- Prevalence and Association of Autoimmune Comorbidities Among Adults with Vitiligo: A Systematic Literature Review and Meta-analysis of USA-Based Studies
- P13 DMARD preconception counselling and reinforcement should be a norm in all rheumatology clinics
- LB1028 Spontaneous keloid eruption in a patient on dialysis
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Chronic Overlapping Pain Conditions and Nociplastic Pain
- 537 Periodontitis may increase risk of alopecia areata: A nationwide population-based cohort study in Korea
- The importance of biomedical engineers in the health system
- Potential etiological factors in frontal fibrosing alopecia
- Effective treatment of alopecia universalis with oral tofacitinib: A case report
- Skin Manifestations of Rheumatological Diseases
- 448 Challenges of securing insurance approval for oral tofacitinib treatment of alopecia areata: A multi-institutional retrospective review
- THE RELATION BETWEEN VITILIGO AND OTHER AUTOIMMUNE DISORDERS
- Autoimmune polyglandular syndrome type 4 – case report
- Romatoid Artritli Hastalarda Metotreksat Toksisitesini Önlemede Yüksek Doz Günlük Folat Desteğine Karşın Düşük Doz Haftalık Folat Desteğinin Etkileri
- Connective Tissue Disorders
- Maladies systémiques associées à la cirrhose biliaire primitive : à propos de 10 cas
- Alopecia areata in childhood
- Egr-1 is main key regulator in IL-17F-induced psoriasin expression in human keratinocytes
- Prevalence of autoimmune diseases and other comorbidities in patients with psoriasis in the United States
- Incidence of serious infectious events with methotrexate treatment: Metaanalysis of randomized controlled trials
- BRITISH ASSOCIATION OF DERMATOLOGY.
- PO.8.170 Drug-induced lupus or systemic lupus erythematosus after experimental COVID-19 therapy: difficulties in differential diagnosis
- First two cases of alopecia areata during golimumab therapy
- Lilly arthritis drug approved for alopecia
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- Chemical Synthetic Disease Modifying Drugs (csDMARD) Used forRheumatoid Arthritis